Boston Scientific Corporation (BSX) key performance indicators and operating metrics (7 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Operating margin, adjusted | 28.00 percent | FY2025-Q3 |
| Earnings per share, adjusted | 0.75 USD_per_share | FY2025-Q3 |
| Capital expenditures | 181M | FY2025-Q3 |
| Gross margin, adjusted | 71.00 percent | FY2025-Q3 |
| Free Cash Flow | 1.16B | FY2025-Q3 |
| Days Sales Outstanding (DSO) | 51.00 | FY2025-Q3 |
| Days Sales Outstanding | 52.00 | FY2025-Q1 |
Back to BSX overview · BSX earnings · BSX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.